Solubility determination, computational modeling, Hansen solubility parameters and apparent thermodynamic analysis of brigatinib in (ethanol + water) mixtures
Author:
Alshahrani Saad M.1, Alfadhel Munerah M.1, Abujheisha Khalil Y.R.1, Almutairy Bjad K.1, Alalaiwe Ahmed S.1, Alshetaili Abdullah S.1, Aldawsari Mohammed F.1, Anwer Md. Khalid1, Shakeel Faiyaz2
Affiliation:
1. Department of Pharmaceutics , College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj , Saudi Arabia 2. Department of Pharmaceutics , College of Pharmacy, King Saud University , Riyadh , Saudi Arabia
Abstract
Abstract
The solubility and various thermodynamic parameters of an antitumor drug brigatinib (BRN) in various ethanol (EtOH) + water (H2O) mixtures were determined in this study. The mole fraction solubility (x
e) of BRN in various (EtOH + H2O) mixtures including pure EtOH and pure H2O was obtained at T = 298.2–323.2 K and p = 0.1 MPa by adopting a saturation shake flask method. Hansen solubility parameters (HSPs) of BRN, pure EtOH, pure H2O and (EtOH + H2O) mixtures free of BRN were also computed. The x
e values of BRN were correlated using Van’t Hoff, Apelblat, Yalkowsky–Roseman, Jouyban–Acree and Jouyban–Acree–Van’t Hoff models with mean errors of <2.0%. The maximum and minimum x
e value of BRN was obtained in pure EtOH (1.43 × 10−2 at T = 323.2 K) and pure H2O (3.08 × 10−6 at T = 298.2 K), respectively. The HSP of BRN was also found more closed with that of pure EtOH. The x
e value of BRN was obtained as increasing significantly with the rise in temperature and increase in EtOH mass fraction in all (EtOH + H2O) mixtures including pure EtOH and pure H2O. The data of apparent thermodynamic analysis showed an endothermic and entropy-driven dissolution of BRN in all (EtOH + H2O) mixtures including pure EtOH and pure H2O.
Funder
Prince Sattam bin Abdulaziz
Publisher
Walter de Gruyter GmbH
Subject
Physical and Theoretical Chemistry
Reference36 articles.
1. Huang, W. S., Liu, S., Zou, D., Thomas, M., Wang, Y., Zhou, T., Romero, J., Kohlmann, A., Li, F., Qi, J., Cai, L., Dwight, T. A., Xu, Y., Xu, R., Dodd, R., Toms, A., Parillon, L., Lu, X., Anjum, R., Zhang, S. J. Med. Chem. 2016, 59, 4948. 2. Sabari, J. K., Santini, F. C., Schram, A. M., Bergagnini, I., Chen, R., Mrad, C., Lai, W. V., Arbour, K. C., Drilon, A. OncoTargets Ther. 2017, 10, 1983. 3. Gettinger, S. N., Bazhenova, L. A., Langer, C. J., Salgia, R., Gold, K. A., Rosell, R., Shaw, A. T., Weiss, G. J., Tugnait, M., Narasimhan, N. I., Dorer, D. J., Kerstein, D., Rivera, V. M., Clackson, T., Haluska, F. G., Camidge, D. R. Lancet Oncol. 2016, 17, 1683. 4. Zhang, S., Anjum, R., Squillace, R., Nadworny, S., Zhou, T., Keats, J., Ning, Y., Wardwell, S. D., Miller, D., Song, Y., Eichinger, L., Moran, L., Huang, W.-S., Liu, S., Zou, D., Wang, Y., Mohemmad, Q., Jang, H. G., Ye, E., Narasimhan, N., Wang, F., Miret, J., Zhu, X., Clackson, T., Dalgarno, D., Shakespeare, W. C., Rivera, V. M. Clin. Canc. Res. 2016, 22, 5527. 5. Alshahrani, S. M., Mohammad, M., Anwer, M. K., Fatima, F., Alshetaili, A. S., Alalaiwe, A., Alsulays, B.B., Shakeel, F. Acta Pol. Pharm. 2019, 76, 225. https://doi.org/10.32383/appdr/94616.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|